0001209191-17-022854.txt : 20170324 0001209191-17-022854.hdr.sgml : 20170324 20170324190526 ACCESSION NUMBER: 0001209191-17-022854 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170323 FILED AS OF DATE: 20170324 DATE AS OF CHANGE: 20170324 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GENOMIC HEALTH INC CENTRAL INDEX KEY: 0001131324 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 770552594 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 301 PENOBSCOT DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 650-556-9300 MAIL ADDRESS: STREET 1: 301 PENOBSCOT DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Shak Steven CENTRAL INDEX KEY: 0001337334 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51541 FILM NUMBER: 17713860 MAIL ADDRESS: STREET 1: 301 PENOBSCOT DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-03-23 0 0001131324 GENOMIC HEALTH INC GHDX 0001337334 Shak Steven 301 PENOBSCOT DRIVE REDWOOD CITY CA 94063 0 1 0 0 Chief Scientific Officer Common Stock 2017-03-23 4 M 0 5000 23.31 A 336103 D Common Stock 2017-03-23 4 S 0 5000 31.2589 D 331103 D Employee Stock Option (right to buy) 23.31 2017-03-23 4 M 0 5000 0.00 D 2017-12-06 Common Stock 0 15000 D Includes an aggregate of 15,154 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested. These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on November 21, 2016. Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated. Represents weighted average sale price. Actual sale prices ranged from $30.83 to $31.59. The option became exercisable as to 25% of the shares on December 6, 2008, and became exercisable as to 1/48th of the shares each full month thereafter. /s/ Jason W. Radford, Attorney-in-fact 2017-03-24